Should I Buy MTUS? MTUS 2026 Analysis

Should You Buy Metallus Inc (MTUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

21.300

1 Day change

2.60%

52 Week Range

21.540

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: no proprietary buy signals, near-term pattern-based odds skew negative (next month bias -6.02%), and earnings are imminent (2/19 after-hours) which can re-price the stock quickly.
Trend is still constructive on moving averages, but today’s -2.69% drop plus a contracting MACD suggests momentum is fading rather than accelerating.
If you must act immediately, MTUS is closer to a “wait/hold” than a “buy now”; the better risk/reward would typically be nearer S1 (~19.32) rather than at 20.75.

Technical Analysis

Price/Trend: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) implies the intermediate trend remains up.
Momentum: MACD histogram is positive (0.0609) but positively contracting → bullish momentum is weakening.
RSI: RSI_6 at 61.65 (neutral-to-slightly-bullish), not signaling an oversold dip-buy.
Key levels: Pivot 20.27; Resistance R1 21.22 then R2 21.81; Support S1 19.32 then S2 18.73. At 20.75, the stock is above pivot but not at a compelling support level.
Quant/pattern read-through: Similar-pattern study suggests downside drift bias (-1.81% next day, -1.55% next week, -6.02% next month), which argues against chasing today.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning/Sentiment: Extremely low put-call (OI PCR 0.02; volume PCR 0.0) indicates heavy call skew / very little put demand → bullish/speculative tone.
Liquidity/Activity: Today’s total option volume is low (42 contracts), so sentiment read is not highly robust.
Volatility: 30D IV ~49.86 vs historical vol ~34.31; IV percentile 73.71 → options are expensive, consistent with upcoming earnings risk being priced in.
Takeaway: Options market leans bullish, but the high IV into earnings favors caution for initiating new long exposure right now (market is already pricing a larger move).

Technical Summary

Sell

Buy

Positive Catalysts

could re-rate the stock.

Neutral/Negative Catalysts

- Earnings risk is imminent (2/19 after-hours): with elevated IV, the market is braced for a meaningful move; disappointment risk is high.
- Near-term statistical bias from similar candlestick patterns points to downside drift over 1D/1W/1M.
- Today’s decline (-2.69%) alongside contracting MACD indicates momentum is cooling.
- Trading trends: Hedge funds and insiders show neutral activity—no supportive “smart money” accumulation signal.

Financial Performance

Latest quarter provided: 2025/Q3.
Revenue: $305.9M, up +34.64% YoY (strong top-line growth).
Profitability: Net income $8.1M, down -237.29% YoY; EPS $0.19, down -235.71% YoY → earnings power deteriorated sharply despite revenue growth.
Margin: Gross margin 11.44, up +114.63% YoY (improving gross profitability), but the drop in net income/EPS implies below-the-line pressure (e.g., operating costs, interest, one-offs) offset gains.
Overall: Mixed fundamentals—sales acceleration and better gross margin, but very weak bottom-line trend heading into the upcoming report.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating changes or price target updates were provided in the data, so a clear Wall Street “pros vs cons” consensus trend cannot be confirmed here.
Practical read from available data: The market’s near-term focus is the Feb 19 earnings event (and options are pricing it), rather than visible analyst-driven upgrades.
Politicians/Influential figures: No recent congress trading data available (no confirmed political buying/selling signal).

Analyst Rating

Wall Street analysts forecast MTUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTUS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 20.760

Low

Averages

High

Current: 20.760

Low

Averages

High

Northcoast

NULL -> Buy

initiated

$24

AI Analysis

2025-07-23

Reason